Loading...
XTSXWBE
Market cap3mUSD
Dec 19, Last price  
0.16CAD
Name

Westbond Enterprises Corp

Chart & Performance

D1W1MN
XTSX:WBE chart
P/E
P/S
0.62
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.74%
Rev. gr., 5y
-4.09%
Revenues
9m
-16.86%
5,652,2706,259,4266,303,3865,739,4366,003,3086,198,3266,085,3506,078,4646,324,4796,599,4407,349,4167,788,0498,969,3719,829,02511,363,16211,363,16211,667,89213,979,80811,089,7939,219,948
Net income
-211k
L
216,298114,69795,28495,385163,608104,05429,015124,135120,66246,655-431,22352,878161,080298,088421,264421,264591,0162,642,997574,550-210,683
CFO
493k
-74.51%
386,495428,109234,899512,241327,300433,208270,597183,390290,365486,321797,072515,956987,4641,294,3891,523,7921,523,7921,676,0784,975,6341,933,280492,814
Dividend
Dec 02, 20220.005 CAD/sh

Profile

WestBond Enterprises Corporation, together with its subsidiary WestBond Industries Inc., manufactures and sells disposable paper products for medical, hygienic, and industrial uses in Canada and the United States. The company offers personal hygiene paper products, such as roll and folded hand towels, jumbo roll and conventional bathroom tissue, coreless tissue, center feed towels, and air-laid center feed towels; hospitality and tabletop paper products comprising air-laid napkins, guest towels, air-laid kitchen roll towels, and disposable bar towels; and clinical products, including sheets, examination table papers, waterproof sheets, pillowcases, examination drapes and gowns, and ultrasound towels and wipers. It also provides long-term care products, including fold and roll air laid patient wipes and waterproof underlays; disinfectant wipes and sprays; and airlaid rolls for converters. It sells its products primarily to medical and industrial distributors, as well as to end-users on a direct basis. WestBond Enterprises Corporation is headquartered in Delta, Canada.
IPO date
Feb 11, 1992
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
9,220
-16.86%
11,090
-20.67%
13,980
19.81%
Cost of revenue
9,368
10,089
10,372
Unusual Expense (Income)
NOPBT
(148)
1,001
3,608
NOPBT Margin
9.02%
25.81%
Operating Taxes
(91)
262
1,009
Tax Rate
26.13%
27.96%
NOPAT
(58)
739
2,599
Net income
(211)
-136.67%
575
-78.26%
2,643
347.20%
Dividends
(534)
(891)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
952
574
932
Long-term debt
3,307
3,853
5,823
Deferred revenue
Other long-term liabilities
37
Net debt
4,148
4,354
5,288
Cash flow
Cash from operating activities
493
1,933
4,976
CAPEX
(410)
(432)
(2,133)
Cash from investing activities
(410)
(432)
(2,133)
Cash from financing activities
(45)
(1,696)
(1,770)
FCF
636
955
1,786
Balance
Cash
111
73
1,466
Long term investments
Excess cash
767
Stockholders' equity
7,294
7,520
7,695
Invested Capital
10,085
10,200
11,248
ROIC
6.89%
23.28%
ROCE
8.18%
25.78%
EV
Common stock shares outstanding
35,626
35,626
35,754
Price
Market cap
EV
EBITDA
1,124
2,159
4,582
EV/EBITDA
Interest
147
143
199
Interest/NOPBT
14.24%
5.50%